Several Indian stocks are likely to remain in focus on September 25, 2026, following important corporate developments ranging from fundraising and rights issues to acquisitions, management changes and business expansion. Natco Pharma, Cochin Shipyard, Inox Green Energy Services and Varun Beverages are among the key names investors are tracking, while Dr Lal PathLabs, Waaree Energies, Sterlite Technologies and JSW Cement also have company specific triggers. The developments are important because they could influence investor sentiment and trading activity, although their eventual impact will depend on execution and broader market conditions.
Natco Pharma: Rights Issue in Focus
Natco Pharma is in focus after its board approved a ₹1,279.36 crore rights issue on September 25. The company plans to issue approximately 1.71 crore equity shares at ₹750 per share.
The rights issue will open on October 12 and close on October 22, 2026. The record date has been fixed for October 1, meaning shareholders holding Natco Pharma shares as of the applicable record date will be eligible for the rights entitlement. Existing shareholders will be entitled to two rights shares for every 21 shares held.
The company has priced the rights shares at a discount to the prevailing market price. For existing shareholders, the key consideration will be whether they participate in the issue, renounce their entitlement or allow the entitlement to lapse. The fundraising will also be watched for its potential impact on the company’s balance sheet and future capital requirements.
Cochin Shipyard: Dutch Acquisition Draws Attention
Cochin Shipyard is another stock to watch after the company acquired a 23% stake in Dutch ship design company Conoship International for €2.30 million.
The transaction gives Cochin Shipyard exposure to an established European ship design business and could strengthen its capabilities in naval architecture and ship design. The development comes at a time when Indian shipbuilders are investing in capacity and looking to participate in a broader global shipbuilding cycle.
Cochin Shipyard has also remained on investors’ radar because of its large order book and exposure to India’s defence and commercial shipbuilding requirements. However, investors need to monitor project execution, margins, working capital and the company’s capital expenditure plans rather than focusing only on order announcements.
Inox Green Energy: QIP Opens
Inox Green Energy Services has entered the spotlight after opening a Qualified Institutions Placement (QIP) on September 24.
The floor price for the issue has been fixed at ₹174.36 per share, with the company having the option to offer a discount of up to 5% to the floor price.
A QIP allows a listed company to raise equity capital from qualified institutional buyers. For Inox Green, investors will be watching the final issue price, size of funds raised and how the proceeds are deployed.
The fundraising comes as renewable energy infrastructure continues to require significant capital for expansion. At the same time, dilution from a fresh equity issue is an important factor existing shareholders need to consider.
Varun Beverages: Senior Management Change
Varun Beverages is also in focus after Chief Operating Officer and senior management personnel Manmohan Rupal Paul resigned, with his resignation effective September 24, 2026.
Management changes can attract attention because operational leadership plays an important role in a large beverage manufacturing and distribution business. Investors will likely monitor any further disclosures regarding the company’s management structure and responsibilities.
Varun Beverages operates in the non alcoholic beverage space and has a large distribution network. Its performance is influenced by volume growth, pricing, input costs, weather conditions and consumer demand.
Dr Lal PathLabs: Acquisition Plans
Dr Lal PathLabs has received attention after its board approved the acquisition of a 70% stake in SN Genelab for up to ₹168 crore.
Following completion, SN Genelab will become a subsidiary of Dr Lal PathLabs. The transaction is expected to be completed by November 30, 2026.
For investors, the important factors to monitor will include the acquisition’s contribution to revenue, integration costs and the potential for expansion in the company’s diagnostic network.
Waaree Energies: Entry Into Specialty Gases
Waaree Energies is in focus after its subsidiary, Waaree Clean Energy Solutions, announced plans to enter India’s specialty gases business.
The company intends to serve customers in areas such as semiconductor and solar cell manufacturing. The move comes as India’s electronics and semiconductor ecosystem develops, creating potential demand for specialised industrial inputs.
However, the business will require investment in manufacturing capabilities, technology and customer relationships. Investors will need to track the pace of commercialisation and financial contribution from the new segment.
Sterlite Technologies: Data Centre Opportunity
Sterlite Technologies has strengthened its data centre product portfolio with pre terminated fibre trunk assemblies designed for high density deployments.
The products cover configurations ranging from 48 fibre to 6,912 fibre and are aimed at hyperscale and enterprise data centres. Demand for high capacity connectivity is being supported by cloud computing, artificial intelligence and data intensive applications.
The key factor for investors will be whether this product expansion translates into meaningful orders and revenue growth.
JSW Cement: GST Notice in Focus
JSW Cement has received a show cause notice involving a proposed GST demand of ₹229.85 crore, along with applicable interest and a 10% penalty, relating to the period from April 2022 to March 2024.
The matter concerns an alleged short payment of GST arising from classification. A show cause notice is not the same as a final tax order, so investors should distinguish between the proposed demand and any eventual determination by the authorities.
Separately, JSW One Platforms has filed a DRHP for a proposed IPO of up to ₹3,054 crore.
What Should Investors Watch Today?
The September 25 stock market session has several company specific triggers, but these developments should be considered in context.
The main factors to monitor include:
- Natco Pharma’s rights issue terms and shareholder participation
- Cochin Shipyard’s Conoship acquisition and order execution
- Inox Green’s QIP pricing and dilution
- Varun Beverages’ management transition
- Dr Lal PathLabs’ acquisition integration
- Waaree Energies’ specialty gases expansion
- Sterlite Technologies’ data centre business
- JSW Cement’s GST matter
These developments can influence individual stocks, but they do not necessarily determine their longer term performance. Investors should consider valuations, earnings, cash flows, balance sheets and industry conditions alongside the latest corporate announcements.
Opportunities and Risks
Fundraising through rights issues and QIPs can provide companies with capital for expansion, debt reduction or new investments. Acquisitions can similarly broaden capabilities and market reach when integration is successful.
However, capital raising can dilute existing shareholders, acquisitions can involve integration risks and new businesses may take time to generate meaningful returns. Regulatory notices can also create uncertainty until the underlying issue is resolved.
Therefore, a stock appearing in the daily “stocks to watch” list should be treated as a signal to examine the underlying development, not as an automatic indication of future price performance.
Conclusion
The stocks to watch today, September 25, include Natco Pharma, Cochin Shipyard, Inox Green Energy Services and Varun Beverages, each for different company specific reasons. Natco Pharma’s ₹1,279 crore rights issue, Cochin Shipyard’s stake acquisition in Conoship, Inox Green’s QIP and Varun Beverages’ senior management change are among the most relevant developments.
Dr Lal PathLabs, Waaree Energies, Sterlite Technologies and JSW Cement also have important corporate updates. Investors should focus on the financial and operational implications of these announcements while keeping broader market volatility and valuation in mind.
Frequently Asked Questions
1. Which stocks are in focus on September 25, 2026?
Natco Pharma, Cochin Shipyard, Inox Green Energy Services and Varun Beverages are among the stocks in focus on September 25 because of recent corporate developments. Dr Lal PathLabs, Waaree Energies, Sterlite Technologies and JSW Cement are also being tracked because of acquisitions, business expansion, fundraising and regulatory developments.
2. Why is Natco Pharma stock in the news today?
Natco Pharma is in focus after its board approved a ₹1,279.36 crore rights issue. The company plans to issue around 1.71 crore shares at ₹750 each. The rights issue is scheduled to open on October 12 and close on October 22, with October 1 set as the record date.
3. What is the Natco Pharma rights issue price?
Natco Pharma has fixed the rights issue price at ₹750 per equity share. Eligible shareholders will receive rights entitlements based on their holdings on the record date. The company has announced an entitlement ratio of two rights shares for every 21 shares held.
4. Why is Cochin Shipyard in focus today?
Cochin Shipyard is in focus after acquiring a 23% stake in Dutch ship design company Conoship International for €2.30 million. The transaction could expand the company’s ship design capabilities and international exposure. Investors will also continue to monitor Cochin Shipyard’s order book, execution, margins and capital expenditure.
5. Why is Inox Green Energy in focus?
Inox Green Energy Services is in focus because it opened a Qualified Institutions Placement on September 24. The floor price has been set at ₹174.36 per share, with a possible discount of up to 5%. Investors will watch the final issue price, funds raised and the potential impact of equity dilution.
6. Why is Varun Beverages in the news?
Varun Beverages is in focus after COO and senior management personnel Manmohan Rupal Paul resigned, effective September 24, 2026. Investors may monitor subsequent management announcements and whether the leadership change has any implications for the company’s operations and business strategy.
7. What happened at Dr Lal PathLabs?
Dr Lal PathLabs has approved the acquisition of a 70% stake in SN Genelab for up to ₹168 crore. After completion, SN Genelab will become a subsidiary. The transaction is expected to be completed by November 30, 2026, subject to the stated conditions.
8. Why is Waaree Energies in focus?
Waaree Energies is in focus after its subsidiary announced entry into India’s specialty gases business. The business is intended to serve sectors including semiconductor and solar cell manufacturing. Investors will need to track investment requirements, commercialisation and the eventual financial contribution from this new business.
9. Why is JSW Cement facing attention today?
JSW Cement has received a show cause notice proposing a GST demand of ₹229.85 crore, plus applicable interest and a 10% penalty, concerning alleged short payment linked to tax classification. A show cause notice is not a final tax determination, so the eventual outcome remains relevant for investors.
10. Should investors buy stocks that are on the stocks to watch list?
Being on a stocks to watch list simply means that a company has a news or corporate trigger that may affect trading interest. It does not establish whether the stock is suitable for investment. Investors should independently assess valuation, financial performance, business risks, cash flows and the likely long term impact of the reported development.
Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as a recommendation or investment advice by Equentis – Research & Ranking. We will not be liable for any losses that may occur. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL & certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.
Jaspreet Singh Arora is the Chief Investment Officer at Equentis, where he heads a seasoned team of equity analysts and turns two decades of market experience into portfolios that consistently beat the benchmark. A go-to voice on cement, building-materials, real-estate, and construction stocks, Jaspreet previously ran research desks at leading brokerages, honing an eye for the metrics that truly move share prices. His plain-spoken analysis helps investors cut through noise and act with conviction. When he’s not deep-diving into earnings calls, you’ll find him unwinding over sports, weekend cricket or a good history podcast.
